Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6699800 | 0.92 | KDM4E (0.37) | KDM4EALDH1A1EPHX2 | |
| SCHEMBL4266840 | 0.88 | KDM4E (0.39) | KDM4EALDH1A1EPHX2 | |
| SCHEMBL6696277 | 0.82 | EPHX2 (0.33) | KDM4EALDH1A1EPHX2 | |
| SCHEMBL6697330 | 0.82 | EPHX2 (0.33) | KDM4EALDH1A1EPHX2 | |
| SCHEMBL6062724 | 0.81 | KDM4E (0.35) | KDM4EALDH1A1EPHX2 | |
| SCHEMBL6063254 | 0.81 | KDM4E (0.35) | KDM4EALDH1A1EPHX2 | |
| SCHEMBL6063691 | 0.80 | KDM4E (0.33) | KDM4EALDH1A1 | |
| SCHEMBL6064487 | 0.79 | KDM4E (0.34) | KDM4EALDH1A1 | |
| SCHEMBL6063177 | 0.79 | KDM4E (0.34) | KDM4EALDH1A1 | |
| SCHEMBL6064010 | 0.79 | KDM4E (0.32) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6777570-B2 | Process for producing norbornene derivative having organosilyl group | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20040063982-A1 | Process for producing norbornene derivative having organosilyl group | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063982-A1 | Process for producing norbornene derivative having organosilyl group | GRIA2, GRM2, GRM8 | KDM4E 2658/4885ALDH1A1 1063/4885EPHX2 4244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.